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ADHERENCE TO THE CLINICAL PRACTICE GUIDELINES IN THE MANAGEMENT
OF CHRONIC ISCHEMIC HEART FAILURE IN A DISTRICT HOSPITAL
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OBJECTIVES: To evaluate the prescribers adherence to the guidelines in the man-
agement of patients with chronic ischemic heart failure and study the effect of
hospitalisation towards their treatment for ischemic heart failure at discharge.
METHODS: The adherence to two guidelines by the prescribers in themanagement
of chronic ischemic heart failure was assessed prospectively between October to
December, 2008.TheMinistry of Health Research and Ethics Committee ofMalaysia
approved the study protocol (NMRR-08-1350-2861). Subjects were 174 patientswith
ischemic heart failure discharged from medical wards at a district government
hospital in Malaysia. Assessment of adherence was based on adherence to the
clinical practice guideline 2007 in management of heart failure by National Heart
Association ofMalaysia, Academy ofMedicine andMinistry of HealthMalaysia and
HFSA 2006 Comprehensive Heart Failure Practice Guideline. RESULTS: : Statins
were the most commonly prescribed treatment at discharge (93.1%) followed by
antiplatelet therapy (89.1%), angiotensin converting enzymes inhibitors (ACEIs)
(60.3%), diuretics (58.6%), beta blockers (56.3%), spironolactone (11.5%), digoxin
(13.2%) and angiotensin receptor blockers (6.9%). ACEIs were more prescribed in
patients without renal dysfunction (p0.001) and beta blockers were less pre-
scribed to patients with history of asthma or pulmonary disease (p0.013). Non-
compliancewas high among the patients at 54.7% (N86). Compliancewas better if
the number of heart failure medications were 4 (p0.010). Hospitalisation of the
patients results in significant improvement in the prescribing of statins at dis-
charge (p0.031).CONCLUSIONS:Overall, the prescription of ACEIs and beta block-
ers at discharge still need to be improved. Non-compliance among the heart failure
patients is common.The prescribed daily dosage for ACEIs and beta blockers at
discharge are lower than the target dose.
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PHARMACEUTICAL CARE INTERVENTION FOR DISEASE MANAGEMENT IN
COMMUNITY PHARMACIES IN AUSTRALIA
Thoopputra T1, Li SC1, Newby DA2, Schneider J1
1University of Newcastle, Callaghan, NSW, Australia, 2University of Newcastle, Waratah, NSW,
Australia
OBJECTIVES: 1) To evaluate the types of diseasemanagement programprovided by
community pharmacy in Australia; 2)To examine existing pharmaceutical care
activities in diabetes management; and 3) to assess perceived barriers for imple-
mentation of diabetes risk assessment service in community pharmacy.
METHODS: A self-administered survey using s structured questionnaire was con-
ducted from October 2011 to January 2012 to collect data from community phar-
macies in the states of Victoria and Queensland. RESULTS: The total responses
numbered 114, representing a 5.7% overall response rate. 111 respondents (97.4%)
reported having existing disease management programs in their practice. The
three main types of disease management program were hypertension manage-
ment (66%), diabetesmanagement (58.4%) andweightmanagement (54%). Approx-
imately 85% of respondents were interested in providing risk assessment service
for chronic disease. There was no statistically significant difference between
branded pharmacy and independent pharmacy in providing pharmaceutical care
activities in diabetes management with patient counselling (32.1%) and diabetes
supplies (31.1%) being the two most common activities . Only 12.7% and 8.9% pro-
vided blood glucose monitoring and awareness program for diabetes respectively.
Lacking of standard guideline and awareness of risk assessment services, shortage
of qualified staffs and no extra remuneration were perceived as major barriers for
implementation of diabetes risk assessment service in community pharmacy. A
sum between AUD10 and AUD50 was suggested as the required remuneration rate
for community pharmacy to provide this service. CONCLUSIONS: The survey re-
sults would imply that most Australian community pharmacies did provide dis-
ease management programs. Most common activities, however, were focusing in
secondary prevention. Several identified barriers to establishing diabetes risk as-
sessment services should be addressed to encourage community pharmacists in
expanding their practice role in chronic disease management through primary
prevention. This would potentially be more cost-effective and deliver improved
health outcomes.
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THE STUDY OF ANTIHYPERGLYCEMIC DRUG USE PATTERNS AND THE
TOWARD CLINICAL EXCELLENCE NETWORK’S DIABETES (TCEN DM)
INDICATORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT
SAMUTSAKHON HOSPITAL
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OBJECTIVES: To describe prescribing patterns, glycemic control and the Toward
Clinical Excellence Network’s Diabetes (TCEN DM) indicators among T2DM pa-
tients at Samutsakhon Hospital, enabling the hospital to evaluate their DM care
practice and further compare the results to other hospitals in Thailand.METHODS:
This retrospective study included randomly selected 349 T2DM patients attending
the outpatient clinic at Samutsakhon Hospital during April 2010 to April 2011. The
patient data were derived from OPD cards and the hospital’s computer database
(HOSxP). RESULTS: Themajority of the patients included were aged between 41-60
years (78.22%) (mean [SD]: 51.26 [8.62] years), with 65.90% being female. The total
number of visits was 2,044 (mean: 5.86 visits/year/patient). The mean number of
antihyperglycemic agents prescribed per visit was 2.02 (range: 2–3), with bigua-
nides and sulfonylureas being most commonly prescribed (86.54% and 79.99%,
respectively). Almost 80% of the patients (76.81%) received combination therapy.
The numbers of visits the patients could have their fasting blood sugar (FBS) and
HbA1c controlled (70-130 mg/dl and 7%) were 638 (33.04%) and 90 (30.93%), re-
spectively. With regard to TCEN DM indicators, only 3 out of 18, i.e. rate of hospi-
talization due to acute DM complications (4.58%), rate of patients having a DM foot
ulcer (3.72%) and rate of patients requiring their foot fingers, foot or leg cut off (0%),
achieved the targets ( 5%, 10% and 0%, respectively). CONCLUSIONS: As ex-
pected, the most commonly prescribed regimen for T2DM is combination therapy
of sulfonylureas and biguanides. Our study, however, reveals that the majority of
patients cannot achieve recommended glycemic goals and a number of TCEN DM
indicators have not achieved the targets yet. These results suggest that the hospital
may need to find a strategy to improve these issues in order to enhance quality of
care and quality of life of T2DM patients.
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HEALTH CARE DECISION MAKING IN MAINLAND CHINA, KOREA, AND
TAIWAN: THE ROAD AHEAD?
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OBJECTIVES: Governments across Asia are confronted with aging populations and
increasing prevalence of chronic diseases such as diabetes. Health care technology
assessment (HTA) is viewed as an important mechanism by which burgeoning
health care costs may be evaluated and controlled. Thus it is important to under-
stand perceived challenges and potential opportunities that exist in the Asian
region in order to appropriately plan evidence based research initiatives to support
HTA. METHODS: In 2011 a Pan-Asian Advisory Panel (Mainland China, Taiwan,
Korea) using a modified delphi methodology was convened in Hong Kong. The
Panel consisted of country-specific experts (n10) in the fields of epidemiology,
health economics, HTA, drug evaluation, and diabetes. RESULTS: Consistent
themes were identified related to research partnerships and regional health issues
such as populations developing diabetes at a younger age due to life-style factors
and obesity. Gaps exist related to the prevalence of non-obese Type 2 diabetes and
the under utilization of insulin. Presently the research in the region is driven by
government, industry and academia, with limited efforts to collaborate across
countries. Data supporting tailored therapeutics, in particular related to improved
safety profiles specific to national populations (rather than generated from sub-
groups within international clinical trials), were highly valued, along with real
world comparative effectiveness research. Specific to diabetes, more studies and
data designed to show impact on complications are sought, given the ever expand-
ing cost of managing these complications of the disease. CONCLUSIONS: This
forum provided the opportunity to gather detailed and wide-ranging opinion from
across the region in a very collegial and constructive manner. There appears to be
great interest in collaborating and executing research across borders. Fostering
such an approach to address common challenges is essential to strengthen the
evidence base for cost-effective and culturally appropriate health care decisions.
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OBJECTIVES: A comprehensive evaluation of unnecessary antibiotic use in adult
Medicaid patients is of high importance given the number of adults covered by
state Medicaid programs is expected to substantially increase due to the recent
health care reform in the United States. This study is the first to examine the
factors associated with unnecessary use of antibiotics across U.S. state Medicaid
programs.METHODS: The study used the 2006-2007Medicaid Analytic Extract files
for all 50 states plus D.C. Index visits for all fee-for-service Medicaid patients21
years were identified as the first office visit with primary diagnoses of cold, URI or
acute bronchitis (ICD-9-CM code 460, 465, 466) in 2006. Index visits with secondary
diagnoses that might warrant appropriate antibiotic use were excluded. The main
outcome was any unnecessary use of antibiotics (i.e. oral antibiotic prescription
filled within 4 days of the index visit). Logistic regressions adjusting for state-level
clustering were used to identify patient characteristics, regional factors, and state-
wide campaigns associated with unnecessary antibiotic use. RESULTS: Approxi-
mately 52% of the 234,775 patients received unnecessary antibiotics. Being White
(OR1.27; 95%CI, 1.15-1.40), female (OR1.07; 95%CI, 1.02-1.13), and having an
acute bronchitis diagnosis (OR3.28; 95% CI, 2.75-3.90), and residing in counties
with lower levels of education were associated with higher likelihood of unneces-
sary antibiotics. Patients residing in the Northeast, Midwest, and South were more
likely to receive unnecessary antibiotics than those residing in the West. Patients
residing in states that participated in the Centers for Disease Control’s Get Smart
Campaign between 2002 and 2005 to encourage appropriate antibiotic prescribing
(OR0.81; 95%CI: 0.68-0.97) had a lower likelihood of unnecessary antibiotic use.
CONCLUSIONS: A high percentage of adult Medicaid enrollees receive antibiotics
unnecessarily. Patient and regional characteristics are correlated with unneces-
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sary antibiotic use. Public health campaignsmayhave an important role in improv-
ing appropriate antibiotic prescribing.
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ASSESSMENT OF DIAGNOSTIC NEED FOR MAGNETIC RESONANCE IMAGING IN
MEDICARE PATIENTS WITH PACEMAKER IMPLANTS
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OBJECTIVES: To estimate the potential unmet need for Magnetic Resonance Imag-
ing (MRI) amongMedicare patients with pacemaker implants, via the prevalence of
diagnoses and conditions for which MRI is the preferred investigation method.
METHODS: The data analyzed comprised of fee-for-service portion of the 2008
Medicare patient population. Using this sample, two issues were examined: the
prevalence of the diseases forwhichMRI is the preferred imagingmodality, and the
uptake rates of all imaging modalities for MRI-indicated beneficiaries with pace-
maker implants compared with those having no implants. For each of those dis-
eases for which MRI is the preferred modality we also identified any trade-offs
between lower MRI rates and higher rates for other imaging modalities in pace-
maker-implanted compared with non-implanted patients. RESULTS: There was
almost no use of MRI in the pacemaker-implanted population, whereas 13% of
patients without any kind of implant received an MRI in 2008. Clinical practice
appears in line with the contraindication for MRI in pacemaker-implanted pa-
tients. Cancer of the CNS and suspected Stroke are conditions which require
timely, accurate imaging for good therapeutic decision making. A total of 73% and
41% of non-paced subjects received whole body MRI for these conditions respec-
tively, compared with 1% of paced subjects for each disease. Similar diagnostic
discrepancies were observed for Motion disorders, Dementia, Chronic orthopaedic
pain and spinal disorders. Pacemaker implanted patients also had high rates of
co-morbidities. CONCLUSIONS: There seems to be a large unmet clinical need for
pacemakers and other implanted cardiac devices which allow MRI to be used as a
diagnostic method. The very high rate of MRI use in non-implanted patients with
acute, progressive and often fatal conditions of stroke and cancer, and its absence
of use in the same patient groups with implants is a concern. The use of MRI
conditional cardiac devices would facilitate greater diagnostic method choice.
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THE MARGIN BETWEEN ACQUISITION COSTS AND REIMBURSEMENT PRICES OF
GENERIC DRUGS (YAKKASA) IN JAPAN: CURRENT STATUS AND
DETERMINANTS
Shibahara H, Shiroiwa T, Shimozuma K
Ritsumeikan University, Kusatsu, Shiga, Japan
OBJECTIVES: The margin between the price of a drug and its reimbursement price
(yakkasa) is determined by negotiation between wholesalers and medical institu-
tions in Japan. The Ministry of Health, Labour andWelfare (MHLW) claims that the
yakkasa reflects the market value of drugs. Factors, however, influencing the yak-
kasa have not been clarified. The aim of this study was to investigate the current
status and determinants of the yakkasa of generic drugs. METHODS: The reim-
bursement price of a drug,which is determined by theMHLW in Japan, decreases in
proportion to the yakkasa every two years. To calculate the yakkasa, we used the
drug price lists of 2006, 2008, and 2010. We identified generic drugs with a higher
percentage margin for each year, and averaged the yakkasa by drugs. We then
investigated longitudinal trends in the range of the yakkasa. Furthermore, we ex-
plored factors associatedwith the larger percentagemargin. RESULTS: The generic
drugs with a higher percentage margin were: doxazosin mesilate (30.7%), famoti-
dine (29.7%), and manidipine hydrochloride (29.6%) in 2006; ofloxacin (31.1%), ceti-
rizine hydrochloride (27.4%), and actarit (25.8%) in 2008; and ofloxacin (24.1%),
cetirizine hydrochloride (23.2%), and levofloxacin (22.5%) in 2010. The yakkasa was
correlatedwith the logarithmic capital of genericmanufacturers, i.e., generic drugs
developed by larger companies had smaller margin. The coefficient of variance for
the yakkasa decreased every two years with the revision of drug prices.
CONCLUSIONS: The generic drugs prescribed frequently or developed recentlyhad
a higher percentage margin. The relationship between the yakkasa and capital
might signify the fact that more competitive manufacturers tend to paysmaller
margin, since medical institutions have no incentive to buy drugs from smaller
manufactures, unless the margin is larger.
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TIME TRENDS AND DETERMINANTS OF PHARMACEUTICAL EXPENDITURE IN
CHINA IN 1990-2009
Shi L1, Yang H1, Cheng G2, Meng Q2
1Tulane University, New Orleans, LA, USA, 2Peking University, Beijing, Beijing, China
OBJECTIVES: China’s national pharmaceutical system has multiple Objectives: to
develop the domestic pharmaceutical industry and encourage innovation, to con-
trol total pharmaceutical expenditure (TPE) which represents the largest compo-
nent of total health expenditure (THE) in China, and to ensure equities for poor and
uninsured patients. The challenges to the current system with distorted market
incentives resulted in unaffordable drug costs and questionable prescribing prac-
tices that undermine public health. This study intended to examine the time trends
and determinants of total pharmaceutical expenditure in China.METHODS: Total
pharmaceutical expenditures over 1990-2009 were explained by amount of pre-
scriptions dispensed, proxy of health utilization, and price index over years includ-
ingmedical CPI. Data from China National Health Accounts Report was used. Time
trends of TPE as share of THE (TPE/THE) and of GDP (TPE/GDP), and the relationship
between TPE and GDP were examined descriptively. The growth of TPE was exam-
ined after adjusting for health utilization. Determinants of TPE/THE and TPE/GDP
were investigated by time-series regression models. RESULTS: Descriptive analy-
ses showed TPE/THE and TPE/GDP grew over the years 1990-2009. THE/GDP grew
faster in the recent few years than TPE/GDP. TPE per visit still rose over years after
adjusting for health utilization (inpatient and outpatient services). However,
health utilization was not shown the growth pattern along with the GDP growth
over 1990s. Time-series analyses showed TPE/THE was negatively influenced by
GDP (p  0.039) and medical CPI (p0.021). TPE/GDP was positively influenced by
price index of prescriptions (p0.000) and amount of health service use including
inpatient (p 0.012) and outpatient visits (p0.003). CONCLUSIONS: Both TPE and
THE increased over timewith the pace of GDP growth. The study provided evidence
of increasing economic burden on patients imposed by TPE in China. Rapid growth
in the China economy, however, may ameliorate the overall TPE burden.
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THE EVALUATION OF VACCINE REFRIGERATOR TEMPERATURE SURVEY
CONDUCTED BY PRIMARY CARE UNITS OF SONGKHLA HOSPITAL
Sae Wong A, Kulthavaporn S
Songkhla Hospital, Ampur Muang, Songkhla provinc, Thailand
OBJECTIVES: To evaluate the quality and improve the quality control of vaccine
refrigerators at primary care units; PCU. METHODS: It was a quasi-experimental
study; pre-post intervention descriptive designwas studied. Computerized Transit
temperature data loggers were used to monitor vaccine refrigerator temperatures
at 19 PCU under the authority of Songkhla hospital. Data loggers, monitoring tem-
peratures from 40 0C to 850C, were programmed to record every 30 minutes for
15 days. Percentage of frequency which temperatures were out of 2-8 0C range and
maximum/minimum temperatures had been used for this evaluation. Results of
the study were sent back to PCU for adjustment.Post adjustment data were col-
lected for assessment RESULTS: Vaccine Refrigerators at PCU were household
models.Refrigerator ages average is 7.37 years. Before intervention, average per-
centage of frequency, which temperatureswere2 0 C and 8 0 C, was 13 .76% and
2.03% (range 0%-81% and 0%-11.23% respectively).19 units recorded temperatures
below 2 0 C and above 8 0 C at one point. The lowest and highest temperatures
recorded were 26.20 0 C and -70C. After assessment, 8 units required modifications
and 11 units got new refrigerators. Refrigerators age average was 2.68 years. Aver-
age percentage of frequency, temperatures2 0 C and 8 0 C, was 3.31% and 0.88%
(range 0%-51.48% and 0.88%-5.34% respectively). 6 units had no out of range tem-
peratures. The lowest and highest temperatures were -2.5 0 C and 190C. The per-
centage of frequency was decreased in 18 units but not statistically significant.
However, the lowest and highest temperatures was statistically significant de-
creased (p-value  0.004, 0.013 respectively) CONCLUSIONS: Using data logger
feedback can help maintain vaccine cold chain standard (2-8 0C). A data logger
should be used continually to monitor temperature in a vaccine refrigerator.
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AFFORDABILITY OF ANTIBACTERIAL MEDICINES IN IRAN DURING 2001-2010
Abdollahiasl A, Jaberidoost M, Farshchi A
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OBJECTIVES: Affordability is one of the main objectives of national drug policies
but there are no clear indicators to determine whether a medicine is affordable.
The share ofmedication in consumer basket, comparing to GrossDomestic Product
(GDP) per capita and comparing to the daily income of the lowest paidworker in the
government have been some methods to judge about the affordability. This study
tries to investigate affordability of antibacterial therapy in Iran during last decade
(2001-2010). METHODS: Annual sales of antibacterial medicines for systemic use
(J01 based on ATC classification) were gathered from Ministry of Health and were
crosschecked by sample data from suppliers and distributors. The cost of medi-
cines according to DDD (Defined Daily Dose) was calculated in Iranian Rials (IRR)
and Dollars (USD) based on average exchange rate in each year. These costs were
compared to GDP per capita, the salary of lowest paid worker in MOH and standard
cost of household basketwhich officially announced by the central bank. RESULTS:
Tetracyclines (J01A) and Sulfonamides (J01E) were the cheapest antibacterial treat-
mentswhile Amphenicoles (J01B) and unclassified antibacterials such as Vancomi-
cine (J01X) were themost expensive treatment for bacterial infections. The average
cost of antibacterial medicines was 0.3USD/DDD which equals to 3.5% of daily
income of the lowest paid worker and 2.5% of daily GDP/capita. The trend of com-
parative costs did not show any significant changes during the period.
CONCLUSIONS: A moderate growth was observed in daily cost of antibacterial
therapy while IRR is the unit of measurement. But when the currency changes to
USD or when costs compare to daily income of the lowest paid worker or to GDP/
Capita, No growth was observed. Apart from changes of the trends, the cost of
antibacterial therapy was too cheap to put a catastrophic expense on the health
system.
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THE IMPLEMENTATION OF ESSENTIAL MEDICINE POLICY IN CHINA: PROS AND
CONS
Hu S1, Zhang Y1, He JJ2
1Shanghai Health Development Research Center, Shanghai, China, 2Shanghai Health
Development Research Center, Shanghai, China
Establishing essential medicine policy (EMP) is one of 5 health system reform pil-
lars in China in 2009. After three-year implementation, the strengthens and weak-
nesses of EMP need to be monitoring and evaluation. OBJECTIVES: The paper re-
views the process of listing, pricing, purchasing, utilization and reimbursement of
essentialmedicines and discusses the achievements and issues of EMP.METHODS:
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